Skip to main content

Animations

MJFF Publications

8531 - 8540 of 8818 Results
Title
Year
  • Year
  • 2018
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2021
  • Summary Details
    OPEN
    Title: A novel extended form of alpha-synuclein 3′UTR in the human brain
    Journal Name: Molecular Brain
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13041-018-0371-x
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2019.00889
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Communication About OFF Periods in Parkinson's Disease: A Survey of Physicians, Patients, and Carepartners
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2019.00892
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-019-0335-3
    Citation Count: 204
  • Summary Details
    OPEN
    Title: Microstructural White Matter Characteristics in Parkinson's Disease With Depression: A Diffusion Tensor Imaging Replication Study
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2019.00884
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Parkinson’s progression prediction using machine learning and serum cytokines
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-019-0086-4
    Citation Count: 98
  • Summary Details
    OPEN
    Title: MAPT p.V363I mutation
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000347
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Genetic risk of Parkinson disease and progression:
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000348
    Citation Count: 148
  • Summary Details
    OPEN
    Title: Spread of α-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41593-019-0457-5
    Citation Count: 242
  • Summary Details
    OPEN
    Title: Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2021.658605
    Citation Count: 14
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.